Cyclosporin A (CSA), FK506, and glucocorticosteroids all inhibit the production of lymphokines by decreasing lymphokine gene expression. Previous experiments have defined six different sites that may contribute to the transcriptional control of the interleukin 2 (IL2) promoter, and for each, active nuclear binding factors are induced upon mitogenic stimulation. While dexamethasone markedly blocks the increase in IL2 mRNA in stimulated human blood T cells, we found that the drug does not block the appearance of factors that bind to the transcriptional control sites termed AP-1, AP-3, NF-kB, OCT 1, B site, and NF-AT. In contrast, both CSA and FK506 have similar effects : the drugs cause modest decreases in AP-3 and NF-kB, and marked decreases in the activity of AP-1 and NF-AT Therefore, CSA and FK506, while chemically different, seem to act upon a similar pathway that leads to IL2 gene expression, whereas glucocorticoids do not affect this pathway.
A tion and lymphokine production. A major site of action of these immunosuppressive drugs is at the level of lym phokine gene expression . This was noted first for cyclosporin A (CSA) (1-4), which acts primarily at the level of lymphokines rather than other components of T cell activation, such as the p55 IL2R and cfos (2) . Two other drugs, dexamethasone and FK506, also act primarily at the level of 11, 2 gene expression (5) (6) (7) . It is likely that glucocorticoids have a different mechanism of action than CSA and FK506, since steroids affect many cell types, whereas CSA and FK506 are more T cell restricted .
To gain more insight into the mechanism ofaction of immunosuppressive drugs, we have taken advantage of recent progress in defining nuclear factors that bind to the IL2 promoter. An activation-dependent enhancer within sequences -326 to -52 of the 5' flanking region of the IL2 gene has been identified (for review see reference 8). In this enhancer reside several elements common to other genes, like the NFkB, AP-1, AP-3, and OCT-1 sites, as well as a site that seems restricted to activated lymphoid cells and is called the nuclear factor for activated T cells (NF-AT) (9) . Here, we report the induction of these nuclear factors in primary populations of human blood T cells . We show that FK-506 and CSA markedly inhibit the activation of factors that bind to the AP-1 and NF-AT sites, whereas dexamethasone has no effect on all six nuclear binding factors tested .
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Materials and Methods
Cell Cultures. Briefly, human mononuclear cells were isolated from huffy coats on Ficoll-Hypaque density gradients, washed in PBS, and rosetted with neuraminidase-treated sheep erythrocytes. The rosette-positive fraction was further purified by passage over a nylon wool column and used as a source of T cells. T cells were cultured at 5 x 106/ml in RPMI 1640 supplemented with 10% heatinactivated FCS, 20,ug/ml gentamicin sulfate, and 5 x 10-5 M 2-ME. Cells were stimulated with PHA (Gibco Laboratories, Grand Island, NY) at 1 Rg/ml and PMA (Sigma Chemical Co., St. Louis, MO) at 5 ng/ml in the presence or absence ofCSA or CSH (Sandoz, Basel, Switzerland) at 1 hg/ml; FK506 (Fujisawa Pharmaceutical Co. Ltd., Osaka, Japan) at 100 ng/ml ; or dexamethasone (Sigma Chemical Co.) at 10-7 M. Nuclear Extracts. These were prepared from 2-4 x 108 T cells by homogenization in two-cell pellet volumes of 10 mM Hepes, pH 7.9, 10 mM KCI, 1.5 mM MgCIZ, 1 mM EDTA, 0.5 mM DTT, 0.5 mM PMSF, and 10% glycerol (10) . Nuclei were centrifuged at 1,000 g for 5 min, washed, and resuspended in two volumes of the above solution . 3 M KCI was added drop by drop to reach 0.39 M KCI . Nuclei were extracted at 4°C for 1 h and centrifuged at 100,000 g for 30 min . The supernatants were dialyzed in 20 mM Hepes, pH 7 .9, 50 mM KCI, 20% glycerol, 0.5 mM PMSF, and 1 mM EDTA, and"then clarified by centrifugation and stored at -80°C. Protein concentration was determined using the Bradford method .
DNA-Protein Binding Assay. 0.2 ng (-10' cpm) ofend-labeled DNA fragments were incubated at room temperature for 20 min with 5-10 jug of nuclear protein in the presence of 2 pg Poly(dl-dC) in 20 jl of 10 mM Tris HCI, pH 7.5, 50 mM NaCl, 1 mM EDTA, 1 mM DTT, and 5% glycerol (this buffer was used for NFkB, NF-AT, and B sites) . For AP-1, AP-3, and OCT-1 sites, the buffer was 20 mM Hepes, pH 7.9, 4% Ficoll, 2.5 MM MgCIZ, 1 mM DTT, and 40 mM KC1. Protein-DNA complexes were separated from free probe on a 4% polyacrylamide gel in 0.25x TBE at 150 V for 1.5 h at room temperature . The gels were dried and exposed to X-ray film . For each site, we verified that a 20-fold molar excess of specific cold oligonucleotide would compete the binding of proteins to a radiolabeled probe, whereas a similar excess from another site would not.
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Suppression of Interleukin 2 Transcription Factors Figure 1 . Effects of CSA on the induction of nuclear factors that bind to elements of the 11,2 enhancer. Human blood T cells were left unstimulated (Unst) or were stimulated with PHA (1 gg/ml) and PMA (5 ng/ml) (PIP) in the presence or absence of CSA or the nonimmunosuppressive analogue CSH (1 Ftg/ml). After 5 h, the cells were collected and nuclear extracts prepared . 10 Rg of nuclear proteins were incubated with 0.2 ng of the indicated 32P end-labeled oligonucleotides. Protein-DNA complexes (arrows) were separated from free oligonucleotide (lower part of each lane) in low ionic strength 4% polyacrylamide gels .
DNA Probes . Oligonucleotides were synthesized by The Rockefeller University Facility with a DNA synthesizer (Applied Biosystems, Inc., Foster City, CA). The following probes were used : the NF-AT binding site, -254 to -285 of the IL-2 promoter, 5'-GGAGGAAAAACTGTTTCATACAGAAGGCGT3' (9); the NF-kB binding site, -206 to -195 region of the 11,2 promoter, 5'-GGGATTTCACCT3' (11); the OCT-1 binding site, 5'-ACT CTTCACCTTATTTGCATAAGCGATTCTA 3', used for the purification of the OTF-1 transcription factor and kindly provided by Dr. N . Heintz (The Rockefeller University) ; the AP-1 binding site, -157 to -140 of the IL2 promoter, 5'-TTCCAAAGAGTCAT Figure 2 . Effects of FK506 on the induction of nuclear factors that bind to elements of the 11,2 enhancer. The experiments were the same as those in Fig. 1 , except that FK506 (100 ng/ml) was used as the immunosuppressant, and nuclear extracts from Hela cells were also tested . Arrows indicate the specific DNA-protein complexes. Results and Discussion DNA-nuclear protein interactions were monitored with standard electrophoretic mobility shift assays (EMSA) . Extracts of nuclei from mitogen stimulated T cells were prepared 5 h after application of the mitogen in the presence or absence of an immunosuppressive drug. Resting T cells did not contain active factors that bind to the NF-AT, NFkB, AP-1, AP-3, and B sites, but these activities were induced by stimulation with PHA and PMA (Fig. 1) . The immunosuppressive CSA, but not the nonimmunosuppressive analogue CSH, markedly inhibited the induction of NF-AT and AP-1, but only partially blocked induction of NF-kB and AP-3 ( Fig.  1) . Inhibition by CSA of NF-AT was also observed in stimulated Jurkat cells (14) . The fact that CSA primarily acts on NF-AT and AP-1 is of interest . Both are distinct from other transcription factors in requiring new protein synthesis as well as two signals, in this case lectin plus PMA (Granelli-Piperno, A., manuscript submitted for publication) . Effects ofdexamethasone on the induction of nuclear factors that bind to elements of the IL2 enhancer. The experiments were the same as those in Fig . 1 , except that dexamethasone (10 -7 M) was used as the immunosuppressive . Arrows indicate the specific DNA-protein complexes .
We next examined the effect of another immunosuppressive drug, FK506 . FK506, like CSA, inhibits T cell proliferation and IL2 gene expression (5), which we confirmed. FK506 proved to be similar to CSA at the level of nuclear transcription factors. The inductions of NF-AT and AP-1 were markedly reduced, whereas AP-3, NF-kB, OCT 1, and the factor that binds to the B site were not (Fig . 2) . We simultaneously evaluated extracts of HeLa cell nuclei . These contained all the nuclear factors that were inducible in T cells, except for NF-AT, thus confirming that NF-AT is at T cell-restricted activity.
In additional experiments, CSA and FK506 blocked the induction of nuclear factors in response to the other mitogens, anti-CD3 (not shown) or anti-CD28 mAb (Fig. 3) . Some authors find that stimulation with anti-CD28 is CSA resistant (15), but we noted that CSA reduced the induction of IL2 mRNA as well as nuclear factors that bind the IL-2 promoter (16) (Fig. 3) .
We last tested dexamethasone, a glucocorticosteroid that also inhibits the increase in IL2 mRNA that occurs during mitogenesis (6, 7) . While the drug clearly blocks the induction of IL-2 mRNA (not shown), dexamethasone did not alter the induction of any of the factors that bind to the elements we have examined (Fig. 4) . These data indicate that the 1172 transcriptional control pathway that is suppressed by glucocorticoids is different from that of CsA and FK506 .
